Author: Michael T. Parker; Smita Gopinath; Corey E. Perez; Melissa M. Linehan; Jason M. Crawford; Akiko Iwasaki; Brett D. Lindenbach
                    Title: Innate Immune Priming by cGAS as a Preparatory Countermeasure Against RNA Virus Infection  Document date: 2018_10_3
                    ID: j1gkl43g_13
                    
                    Snippet: to cytomegalovirus infection was cell type-dependent, despite active cGAS-STING 326 expression. Where cGAMP was detected, levels were on the order of 5 fmol/10 4 327 cells, or ~3x10 5 molecules/cell, which was slightly above their assay's limit of 328 detection (53). As our biochemical and biological assays were both less sensitive 329 than that of Paijo et al., we surmise that the synthesis of cGAMP in response to RNA 330 virus infection is belo.....
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: to cytomegalovirus infection was cell type-dependent, despite active cGAS-STING 326 expression. Where cGAMP was detected, levels were on the order of 5 fmol/10 4 327 cells, or ~3x10 5 molecules/cell, which was slightly above their assay's limit of 328 detection (53). As our biochemical and biological assays were both less sensitive 329 than that of Paijo et al., we surmise that the synthesis of cGAMP in response to RNA 330 virus infection is below the limit of detection and/or may be rapidly turned over. 331 Alternatively, continuous low-level production of cGAMP in response to endogenous 332 DNA ligands may be more relevant to RNA virus restriction. Clearly, cGAMP assays 333 with improved sensitivity are needed to discern between these possibilities. 334
 
  Search related documents: 
                                Co phrase  search for related documents- cell type and detection limit: 1, 2, 3, 4, 5, 6, 7, 8
- cell type and dna ligand: 1, 2
- cell type and low level: 1, 2, 3, 4, 5, 6, 7, 8
- cell type and low level production: 1
- cell type and molecule cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- cell type and virus infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- cell type and virus restriction: 1, 2, 3, 4, 5, 6, 7, 8
- cgamp detect and detection limit: 1
- cgamp detect and low level: 1
- cgamp detect and RNA virus restriction: 1, 2
- cgamp detect and virus infection: 1, 2
- cgamp detect and virus restriction: 1, 2
- cgamp synthesis and detection limit: 1
- cgamp synthesis and low level: 1
- cgamp synthesis and RNA virus restriction: 1, 2
- cgamp synthesis and virus infection: 1, 2
- cgamp synthesis and virus restriction: 1, 2
- cytomegalovirus infection and detection limit: 1
- cytomegalovirus infection and virus infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50
 
                                Co phrase  search for related documents, hyperlinks ordered by date